110 related articles for article (PubMed ID: 35368039)
1. PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity.
Maskin CR; Raman R; Houvras Y
Sci Rep; 2022 Apr; 12(1):5573. PubMed ID: 35368039
[TBL] [Abstract][Full Text] [Related]
2. A role for ATF2 in regulating MITF and melanoma development.
Shah M; Bhoumik A; Goel V; Dewing A; Breitwieser W; Kluger H; Krajewski S; Krajewska M; Dehart J; Lau E; Kallenberg DM; Jeong H; Eroshkin A; Bennett DC; Chin L; Bosenberg M; Jones N; Ronai ZA
PLoS Genet; 2010 Dec; 6(12):e1001258. PubMed ID: 21203491
[TBL] [Abstract][Full Text] [Related]
3. Acetylation reprograms MITF target selectivity and residence time.
Louphrasitthiphol P; Loffreda A; Pogenberg V; Picaud S; Schepsky A; Friedrichsen H; Zeng Z; Lashgari A; Thomas B; Patton EE; Wilmanns M; Filippakopoulos P; Lambert JP; Steingrímsson E; Mazza D; Goding CR
Nat Commun; 2023 Sep; 14(1):6051. PubMed ID: 37770430
[TBL] [Abstract][Full Text] [Related]
4. Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.
Wellbrock C; Arozarena I
Pigment Cell Melanoma Res; 2015 Jul; 28(4):390-406. PubMed ID: 25818589
[TBL] [Abstract][Full Text] [Related]
5. A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF.
Choi J; Xu M; Makowski MM; Zhang T; Law MH; Kovacs MA; Granzhan A; Kim WJ; Parikh H; Gartside M; Trent JM; Teulade-Fichou MP; Iles MM; Newton-Bishop JA; Bishop DT; MacGregor S; Hayward NK; Vermeulen M; Brown KM
Nat Genet; 2017 Sep; 49(9):1326-1335. PubMed ID: 28759004
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis.
Shabna A; Antony J; Vijayakurup V; Saikia M; Liju VB; Retnakumari AP; Amrutha NA; Alex VV; Swetha M; Aiswarya SU; Jannet S; Unni US; Sundaram S; Sherin DR; Anto NP; Bava SV; Chittalakkottu S; Ran S; Anto RJ
Cell Mol Life Sci; 2022 Aug; 79(9):478. PubMed ID: 35948813
[TBL] [Abstract][Full Text] [Related]
7. PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell Differentiation.
Johansson JA; Marie KL; Lu Y; Brombin A; Santoriello C; Zeng Z; Zich J; Gautier P; von Kriegsheim A; Brunsdon H; Wheeler AP; Dreger M; Houston DR; Dooley CM; Sims AH; Busch-Nentwich EM; Zon LI; Illingworth RS; Patton EE
Dev Cell; 2020 Aug; 54(3):317-332.e9. PubMed ID: 32652076
[TBL] [Abstract][Full Text] [Related]
8. TFAP2 paralogs facilitate chromatin access for MITF at pigmentation and cell proliferation genes.
Kenny C; Dilshat R; Seberg HE; Van Otterloo E; Bonde G; Helverson A; Franke CM; Steingrímsson E; Cornell RA
PLoS Genet; 2022 May; 18(5):e1010207. PubMed ID: 35580127
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-associated mutations in protein phosphatase 6 cause chromosome instability and DNA damage owing to dysregulated Aurora-A.
Hammond D; Zeng K; Espert A; Bastos RN; Baron RD; Gruneberg U; Barr FA
J Cell Sci; 2013 Aug; 126(Pt 15):3429-40. PubMed ID: 23729733
[TBL] [Abstract][Full Text] [Related]
10. FOXQ1 controls the induced differentiation of melanocytic cells.
Bagati A; Bianchi-Smiraglia A; Moparthy S; Kolesnikova K; Fink EE; Kolesnikova M; Roll MV; Jowdy P; Wolff DW; Polechetti A; Yun DH; Lipchick BC; Paul LM; Wrazen B; Moparthy K; Mudambi S; Morozevich GE; Georgieva SG; Wang J; Shafirstein G; Liu S; Kandel ES; Berman AE; Box NF; Paragh G; Nikiforov MA
Cell Death Differ; 2018 Jun; 25(6):1040-1049. PubMed ID: 29463842
[TBL] [Abstract][Full Text] [Related]
11. A unique hyperdynamic dimer interface permits small molecule perturbation of the melanoma oncoprotein MITF for melanoma therapy.
Liu Z; Chen K; Dai J; Xu P; Sun W; Liu W; Zhao Z; Bennett SP; Li P; Ma T; Lin Y; Kawakami A; Yu J; Wang F; Wang C; Li M; Chase P; Hodder P; Spicer TP; Scampavia L; Cao C; Pan L; Dong J; Chen Y; Yu B; Guo M; Fang P; Fisher DE; Wang J
Cell Res; 2023 Jan; 33(1):55-70. PubMed ID: 36588115
[TBL] [Abstract][Full Text] [Related]
12. pH-controlled histone acetylation amplifies melanocyte differentiation downstream of MITF.
Raja DA; Gotherwal V; Burse SA; Subramaniam YJ; Sultan F; Vats A; Gautam H; Sharma B; Sharma S; Singh A; Sivasubbu S; Gokhale RS; Natarajan VT
EMBO Rep; 2020 Jan; 21(1):e48333. PubMed ID: 31709752
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma.
Muccioli S; Brillo V; Varanita T; Rossin F; Zaltron E; Velle A; Alessio G; Angi B; Severin F; Tosi A; D'Eletto M; Occhigrossi L; Falasca L; Checchetto V; Ciaccio R; Fascì A; Chieregato L; Rebelo AP; Giacomello M; Rosato A; Szabò I; Romualdi C; Piacentini M; Leanza L
Cell Death Dis; 2023 Oct; 14(10):704. PubMed ID: 37898636
[TBL] [Abstract][Full Text] [Related]
14. DNA damage remodels the MITF interactome to increase melanoma genomic instability.
Binet R; Lambert JP; Tomkova M; Tischfield S; Baggiolini A; Picaud S; Sarkar S; Louphrasitthiphol P; Dias D; Carreira S; Humphrey TC; Fillipakopoulos P; White R; Goding CR
Genes Dev; 2024 Feb; 38(1-2):70-94. PubMed ID: 38316520
[TBL] [Abstract][Full Text] [Related]
15. GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation.
Shinzawa K; Matsumoto S; Sada R; Harada A; Saitoh K; Kato K; Ikeda S; Hirayama A; Yokoi K; Tanemura A; Nimura K; Ikawa M; Soga T; Kikuchi A
Oncogene; 2023 Oct; 42(42):3142-3156. PubMed ID: 37658191
[TBL] [Abstract][Full Text] [Related]
16. Loss of prdm1a accelerates melanoma onset and progression.
Iwanaga R; Truong BT; Hsu JY; Lambert KA; Vyas R; Orlicky D; Shellman YG; Tan AC; Ceol C; Artinger KB
Mol Carcinog; 2020 Sep; 59(9):1052-1063. PubMed ID: 32562448
[TBL] [Abstract][Full Text] [Related]
17. MITF regulates IDH1 and NNT and drives a transcriptional program protecting cutaneous melanoma from reactive oxygen species.
Roider E; Lakatos AIT; McConnell AM; Wang P; Mueller A; Kawakami A; Tsoi J; Szabolcs BL; Ascsillán AA; Suita Y; Igras V; Lo JA; Hsiao JJ; Lapides R; Pál DMP; Lengyel AS; Navarini A; Okazaki A; Iliopoulos O; Németh I; Graeber TG; Zon L; Giese RW; Kemeny LV; Fisher DE
bioRxiv; 2023 Nov; ():. PubMed ID: 38014031
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic K-Ras
Ito M; Tanuma N; Kotani Y; Murai K; Kondo A; Sumiyoshi M; Shima H; Matsuda S; Watanabe T
FEBS Open Bio; 2024 Apr; 14(4):545-554. PubMed ID: 38318686
[TBL] [Abstract][Full Text] [Related]
19. Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma.
Basu R; Kulkarni P; Qian Y; Walsh C; Arora P; Davis E; Duran-Ortiz S; Funk K; Ibarra D; Kruse C; Mathes S; McHugh T; Brittain A; Berryman DE; List EO; Okada S; Kopchick JJ
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31547367
[TBL] [Abstract][Full Text] [Related]
20. Revealing mitf functions and visualizing allografted tumor metastasis in colorless and immunodeficient Xenopus tropicalis.
Ran R; Li L; Xu T; Huang J; He H; Chen Y
Commun Biol; 2024 Mar; 7(1):275. PubMed ID: 38443437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
